formats

Novo Nordisk cuts sales forecast

Danish insulin manufacturer has posted 15 percent growth in first-quarter operating profit but cut its sales outlook for 2014.

All rights reserved to: UIG | United Investment Group 2012 , Powered By: UCG.ae